Thalidomide OK for severe childhood arthritis
|
Tweet
|
|
Thalidomide, the drug that caused a spate of birth defects back in the 60s, may redeem itself as a treatment for children with a severe form of arthritis—called systemic onset juvenile rheumatoid arthritis, or SoJRA—according to a new study.
“Children with SoJRA often have a poor outcome because of chronic inflammation and corticosteroid side effects,” Dr. Thomas J. A. Lehman, of the Hospital for Special Surgery, in New York, and colleagues write in the Journal of Pediatrics.
"Thalidomide is a unique anti-inflammatory agent,” they explain, that suppresses several inflammatory factors.
The team studied 13 children who had not responded to conventional therapy and were given thalidomide and followed for 6 months. Eleven of the patients had a sustained response to the drug with adequate disease control. Improvement was observed within 4 weeks in most patients.
On average, the children were able to reduce their dose of steroids by about two-thirds over the 6-month period, and six of them were able to discontinue prednisone.
The team saw a decrease in the average number of affected joints—from 19 to 6—and none of the patients had an increase in their affected joint count.
Only minor side effects were reported. Numbness and tingling were common at the start of treatment, but all the participants were able to continue on treatment at the same or a decreased dosage.
“The risks of the low dosage of thalidomide used in this study are acceptable” when compared with the permanent physical and psychological consequences of prolonged high-dose steroid therapy, Lehman’s group says.
“Further,” they add, “the possible toxicities of thalidomide are small when compared with those of autologous stem cell transplantation and other proposed salvage therapies for severe SoJRA.”
SOURCE: Journal of Pediatrics, December 2004.
Revision date: June 14, 2011
Last revised: by Andrew G. Epstein, M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

